069620.KS
069620.KS
KR7069620003
DAEWOONG PHARM
Loading chart...

Company Profile

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Related stocks

185750.KS
185750.KS • South Korea
CHONGKUNDANG
65,900 KRW
647.98M USD 1Y -19.9%
195940.KQ
195940.KQ • South Korea
HK inno.N
39,700 KRW
839.31M USD 1Y -13.3%
000566.SZ
000566.SZ • China
HAINAN HAIYAO
4.71 CNY
914.35M USD 1Y -13.7%
003850.KS
003850.KS • South Korea
Boryung
8,610 KRW
525.24M USD 1Y +0.2%
000915.SZ
000915.SZ • China
WIT DYNE
24.22 CNY
849.25M USD 1Y -23.8%
006280.KS
006280.KS • South Korea
GC Biopharma Corp.
129,400 KRW
1.1B USD 1Y -2.2%
002390.SZ
002390.SZ • China
XINBANG PHAR.
3.01 CNY
875.5M USD 1Y -19.5%
600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
41.9% p.a.
Max Drawdown (5Y)
-52.3%
Sharpe Ratio (5Y)
-0.16
Beta Factor
0.00
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (41.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -70.8% in the extended horizon.
ende